Evidence map›Paper›PMID 38854540›Full record

ArticleACS omega2024

Praful Kumar Majhi, Samir Sayyad, Mahendra Gaur, Gangadhar Kedar, Shankar Rathod, Rajanikant Sahu, Prasanna Kumar Pradhan, Shyamalendu Tripathy, Goutam Ghosh, Bharat Bhusan Subudhi

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. [Drug repositioning prediction based on dynamic feature learning on heterogeneous graphs].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  2. Review
  3. Network Pharmacology, Molecular Docking andCurrent computer-aided drug design · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Praful Kumar MajhiDrug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.
Samir SayyadVitely Bio LLP, Ahmedabad , Gujarat 380054, India.
Mahendra GaurDrug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.ORCID https://orcid.org/0000-0001-5800-7668
Gangadhar KedarVitely Bio LLP, Ahmedabad , Gujarat 380054, India.
Shankar RathodVitely Bio LLP, Ahmedabad , Gujarat 380054, India.
Rajanikant SahuDrug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.
Prasanna Kumar PradhanPioneer Pharmacy College, Vadodara, Gujarat 390019, India.
Shyamalendu TripathyDrug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.
Goutam GhoshDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.
Bharat Bhusan SubudhiDrug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751029, India.ORCID https://orcid.org/0000-0002-2411-7292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38854540
PMCPMC11154920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.